"Dr. Tolutope Oyasiji is a board certified general surgeon and fellowship trained surgical oncologist at Karmanos Cancer Institute at McLaren Flint."

During the past decade, McLaren Cancer Institute-Flint conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 39 clinical trials were completed, i.e. on average, 84.8% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 17 clinical trials were completed. i.e. 94.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McLaren Cancer Institute-Flint" #1 sponsor was "Radiation Therapy Oncology Group" with 46 trials, followed by "National Cancer Institute (NCI)" with 25 trials sponsored, "NRG Oncology" with 15 trials sponsored, "SWOG Cancer Research Network" with 15 trials sponsored and "Alliance for Clinical Trials in Oncology" with 15 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McLaren Cancer Institute-Flint" #1 collaborator was "National Cancer Institute (NCI)" with 101 trials as a collaborator, "NRG Oncology" with 24 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "Radiation Therapy Oncology Group" with 7 trials as a collaborator and "SWOG Cancer Research Network" with 7 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "McLaren Cancer Institute-Flint" are "Breast Cancer" (17 trials), "Prostate Cancer" (13 trials), "Lung Cancer" (11 trials), "Head and Neck Cancer" (9 trials) and "Metastatic Cancer" (6 trials). Many other conditions were trialed in "McLaren Cancer Institute-Flint" in a lesser frequency.

Most popular intervention types in "McLaren Cancer Institute-Flint" are "Drug" (84 trials), "Radiation" (77 trials), "Other" (47 trials), "Procedure" (34 trials) and "Biological" (28 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (31 trials), "Quality-of-Life Assessment" (23 trials), "Laboratory Biomarker Analysis" (19 trials), "Questionnaire Administration" (16 trials) and "Intensity-Modulated Radiation Therapy" (11 trials). Other intervention names were less common.

The vast majority of trials in "McLaren Cancer Institute-Flint" are 88 trials for "All" genders, 24 trials for "Female" genders and 17 trials for "Male" genders.

Currently, there are NaN active trials in "McLaren Cancer Institute-Flint". undefined are not yet recruiting, 17 are recruiting, 40 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in McLaren Cancer Institute-Flint, 3 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in McLaren Cancer Institute-Flint, 11 "Phase 1" clinical trials were conducted, 46 "Phase 2" clinical trials and 79 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".